HBEGF and in situ carcinoma: Finally, in line with our observations in patients with CIS and RRMS (Fig. 2i and Extended Data Fig. 1f), we observed no major differences in the seroabundance of HB-EGF during EAE, further supporting its CNS-specific regulation.